CNS Drugs (2019) 33(3):20923
Peripheral GLP-1 released after meals activates vagal afferent fibres that signal satiety to the brain
Pharmacokinetics of oral cyanocobalamin formulated with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC): an open-label, randomized, single-dose, parallel-group study in healthy male subjects
Whilst the theoretical benefits of GLP-1 receptor agonists in inflammatory conditions are being explored in research settings, patients considering this approach must understand both the potential advantages and significant risks associated with off-label use
However, for others, reduced intake can backfire if it leads to dehydration, low fiber intake, or irregular bowel movements
The most rapid weight loss occurred between weeks 12 and 24, when participants were on stable maintenance doses and adaptation to side effects had occurred